Notice of Results and Investor Presentation

Cambridge Nutritional Sciences PLC

06 November 2023

 

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Notice of Results and Investor Presentation

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will issue its Half Year results for the six months ended 30 September 2023 on Thursday 23 November 2023.

Investor presentation

Jag Grewal, CEO and Simon Douglas, Chairman will provide a live presentation relating to the Half Year Results via the Investor Meet Company platform on Thursday 23 November 2023 at 16:30 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Cambridge Nutritional Sciences plc via: 

https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor

Investors who already follow Cambridge Nutritional Sciences plc on the Investor Meet Company platform will automatically be invited.

Contacts: 

Cambridge Nutritional Sciences plc			www.cnsplc.com
Jag Grewal, Chief Executive Officer		via Walbrook PR
Cavendish Capital Markets Limited			Tel: [phone]
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Sam Allen			Mob: [phone]

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

END